Ontology highlight
ABSTRACT:
SUBMITTER: Franchi F
PROVIDER: S-EPMC6978557 | biostudies-literature | 2019 Nov
REPOSITORIES: biostudies-literature
Franchi Francesco F Rollini Fabiana F Kairouz Victor V Rivas Rios Jose J Rivas Andrea A Agarwal Malhar M Briceno Maryuri M Wali Mustafa M Nawaz Ahmed A Silva Gabriel G Shaikh Zubair Z Maaliki Naji N Been Latonya L Piraino Jason J Pineda Andres M AM Suryadevara Siva S Soffer Daniel D Zenni Martin M MM Jennings Lisa K LK Bass Theodore A TA Angiolillo Dominick J DJ
JACC. Basic to translational science 20190901 7
Vorapaxar reduces thrombotic cardiovascular events at the expense of increased bleeding. However, the differential pharmacodynamic (PD) effects of vorapaxar according to diabetes mellitus (DM) status are unknown. Moreover, although withdrawal of aspirin has emerged as a bleeding reduction strategy, the PD effects of stopping aspirin in patients treated with vorapaxar also are unknown. In this prospective PD investigation, vorapaxar was associated with reduced platelet-mediated thrombogenicity wi ...[more]